Literature DB >> 21638778

Dietary-resistant starch improves maternal glycemic control in Goto-Kakizaki rat.

Li Shen1, Michael J Keenan, Anne Raggio, Cathy Williams, Roy J Martin.   

Abstract

SCOPE: Dietary prebiotics show potential in anti-diabetes. Dietary resistant starch (RS) has a favorable impact on gut hormone profiles, including glucagon-like peptide-1 (GLP-1) consistently released, a potent anti-diabetic incretin. Also RS reduced body fat and improved glucose tolerance in rats and mice. In the current project, we hypothesize that dietary-resistant starch can improve insulin sensitivity and pancreatic β cell mass in a type 2 diabetic rat model. Altered gut fermentation and microbiota are the initial mechanisms, and enhancement in serum GLP-1 is the secondary mechanism. METHODS AND
RESULTS: In this study, GK rats were fed an RS diet with 30% RS and an energy control diet. After 10 wk, these rats were mated and went through pregnancy and lactation. At the end of the study, pancreatic β cell mass, insulin sensitivity, pancreatic insulin content, total GLP-1 levels, cecal short-chain fatty acid concentrations and butyrate producing bacteria in cecal contents were greatly improved by RS feeding. The offspring of RS-fed dams showed improved fasting glucose levels and normal growth curves.
CONCLUSION: Dietary RS is potentially of great therapeutic importance in the treatment of diabetes and improvement in outcomes of pregnancy complicated by diabetes.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21638778      PMCID: PMC4826617          DOI: 10.1002/mnfr.201000605

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  47 in total

1.  Preconception care of women with diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

Review 2.  Resistant starch: metabolic effects and potential health benefits.

Authors:  Janine A Higgins
Journal:  J AOAC Int       Date:  2004 May-Jun       Impact factor: 1.913

Review 3.  The gut and energy balance: visceral allies in the obesity wars.

Authors:  Michael K Badman; Jeffrey S Flier
Journal:  Science       Date:  2005-03-25       Impact factor: 47.728

4.  Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers.

Authors:  Michael A Nauck; Markus M Heimesaat; Kai Behle; Jens J Holst; Markus S Nauck; Robert Ritzel; Michael Hüfner; Wolff H Schmiegel
Journal:  J Clin Endocrinol Metab       Date:  2002-03       Impact factor: 5.958

5.  Peptide YY and proglucagon mRNA expression patterns and regulation in the gut.

Authors:  Jun Zhou; Maren Hegsted; Kathleen L McCutcheon; Michael J Keenan; Xiaochun Xi; Anne M Raggio; Roy J Martin
Journal:  Obesity (Silver Spring)       Date:  2006-04       Impact factor: 5.002

6.  Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus.

Authors:  Charlotte M Boney; Anila Verma; Richard Tucker; Betty R Vohr
Journal:  Pediatrics       Date:  2005-03       Impact factor: 7.124

7.  Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults.

Authors:  Nadja Larsen; Finn K Vogensen; Frans W J van den Berg; Dennis Sandris Nielsen; Anne Sofie Andreasen; Bente K Pedersen; Waleed Abu Al-Soud; Søren J Sørensen; Lars H Hansen; Mogens Jakobsen
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

8.  Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.

Authors:  Loredana Farilla; Angela Bulotta; Boaz Hirshberg; Sergio Li Calzi; Nasif Khoury; Houtan Noushmehr; Cristina Bertolotto; Umberto Di Mario; David M Harlan; Riccardo Perfetti
Journal:  Endocrinology       Date:  2003-08-28       Impact factor: 4.736

Review 9.  Type 2 diabetes - a matter of failing beta-cell neogenesis? Clues from the GK rat model.

Authors:  J Movassat; S Calderari; E Fernández; M A Martín; F Escrivá; C Plachot; M N Gangnerau; P Serradas; C Alvarez; B Portha
Journal:  Diabetes Obes Metab       Date:  2007-11       Impact factor: 6.577

10.  Higher maternal than paternal inheritance of diabetes in GK rats.

Authors:  D Gauguier; I Nelson; C Bernard; V Parent; C Marsac; D Cohen; P Froguel
Journal:  Diabetes       Date:  1994-02       Impact factor: 9.461

View more
  29 in total

Review 1.  Improving healthspan via changes in gut microbiota and fermentation.

Authors:  Michael J Keenan; Maria L Marco; Donald K Ingram; Roy J Martin
Journal:  Age (Dordr)       Date:  2015-09-14

2.  The importance of GLP-1 and PYY in resistant starch's effect on body fat in mice.

Authors:  June Zhou; Roy J Martin; Anne M Raggio; Li Shen; Kathleen McCutcheon; Michael J Keenan
Journal:  Mol Nutr Food Res       Date:  2015-03-02       Impact factor: 5.914

3.  Effects of a diet rich in arabinoxylan and resistant starch compared with a diet rich in refined carbohydrates on postprandial metabolism and features of the metabolic syndrome.

Authors:  Anne Grethe Schioldan; Søren Gregersen; Stine Hald; Ann Bjørnshave; Mette Bohl; Bolette Hartmann; Jens Juul Holst; Hans Stødkilde-Jørgensen; Kjeld Hermansen
Journal:  Eur J Nutr       Date:  2017-01-09       Impact factor: 5.614

4.  Role of resistant starch on diabetes risk factors in people with prediabetes: Design, conduct, and baseline results of the STARCH trial.

Authors:  Kara L Marlatt; Ursula A White; Robbie A Beyl; Courtney M Peterson; Corby K Martin; Maria L Marco; Michael J Keenan; Roy J Martin; Kayanush J Aryana; Eric Ravussin
Journal:  Contemp Clin Trials       Date:  2017-12-21       Impact factor: 2.226

5.  Obese ZDF rats fermented resistant starch with effects on gut microbiota but no reduction in abdominal fat.

Authors:  Felicia Goldsmith; Justin Guice; Ryan Page; David A Welsh; Christopher M Taylor; Eugene E Blanchard; Meng Luo; Anne M Raggio; Rhett W Stout; Diana Carvajal-Aldaz; Amanda Gaither; Christine Pelkman; Jianping Ye; Roy J Martin; James Geaghan; Holiday A Durham; Diana Coulon; Michael J Keenan
Journal:  Mol Nutr Food Res       Date:  2016-08-11       Impact factor: 5.914

6.  High-amylose resistant starch increases hormones and improves structure and function of the gastrointestinal tract: a microarray study.

Authors:  Michael J Keenan; Roy J Martin; Anne M Raggio; Kathleen L McCutcheon; Ian L Brown; Anne Birkett; Susan S Newman; Jihad Skaf; Maren Hegsted; Richard T Tulley; Eric Blair; June Zhou
Journal:  J Nutrigenet Nutrigenomics       Date:  2012-04-20

7.  Dietary resistant starch improves selected brain and behavioral functions in adult and aged rodents.

Authors:  June Zhou; Michael J Keenan; Sun Ok Fernandez-Kim; Paul J Pistell; Donald K Ingram; Bing Li; Anne M Raggio; Li Shen; Hanjie Zhang; Kathleen L McCutcheon; Richard T Tulley; Marc R Blackman; Jeffrey N Keller; Roy J Martin
Journal:  Mol Nutr Food Res       Date:  2013-07-01       Impact factor: 5.914

8.  Maternal ileal interposition surgery confers metabolic improvements to offspring independent of effects on maternal body weight in UCD-T2DM rats.

Authors:  Bethany P Cummings; James L Graham; Kimber L Stanhope; Michael L Chouinard; Peter J Havel
Journal:  Obes Surg       Date:  2013-12       Impact factor: 4.129

Review 9.  Resistant starch: promise for improving human health.

Authors:  Diane F Birt; Terri Boylston; Suzanne Hendrich; Jay-Lin Jane; James Hollis; Li Li; John McClelland; Samuel Moore; Gregory J Phillips; Matthew Rowling; Kevin Schalinske; M Paul Scott; Elizabeth M Whitley
Journal:  Adv Nutr       Date:  2013-11-06       Impact factor: 8.701

10.  High fat diet partially attenuates fermentation responses in rats fed resistant starch from high-amylose maize.

Authors:  Jason A Charrier; Roy J Martin; Kathleen L McCutcheon; Anne M Raggio; Felicia Goldsmith; M'famara Goita; Reshani N Senevirathne; Ian L Brown; Christine Pelkman; June Zhou; John Finley; Holiday A Durham; Michael J Keenan
Journal:  Obesity (Silver Spring)       Date:  2013-07-02       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.